MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced plans to introduce two of its next-generation cardiovascular devices in Japan, the world’s second largest market for advanced medical technology: the Integrity® Coronary Stent System for the treatment of narrowed heart arteries due to atherosclerosis and the Endurant® AAA Stent Graft System for the treatment of abdominal aortic aneurysms.